Has Miguel Rivera, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,953 in general payments to Miguel Rivera, MD across 379 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Miguel Rivera, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Miguel Rivera, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Miguel Rivera, MD

Endocrinology, Diabetes & Metabolism · Metairie, LANPI 1104840404

Payments from drug & device makers

$6,953in general payments, 2019–2025

Across 379 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Antares Pharma, Inc.$603
AstraZeneca$599
Novo Nordisk$538
BETA Bionics, Inc.$486
Lilly USA, LLC$485
AbbVie$435
plus $4K from 43 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Antares Pharma, Inc.	33	$603
AstraZeneca(2 entities)	31	$599
Novo Nordisk	40	$538
BETA Bionics, Inc.	11	$486
Lilly USA, LLC	29	$485
AbbVie(2 entities)	30	$435
Xeris Pharmaceuticals, Inc.	24	$376
Dexcom, Inc.	14	$363
Boehringer Ingelheim	15	$253
Corcept Therapeutics	12	$237
Bayer	10	$204
Amarin Pharma, Inc.	10	$165
Abbott	9	$164
Clarus Therapeutics Inc.	9	$161
Insulet Corporation	5	$129
Amneal Pharmaceuticals LLC	9	$127
Ascendis Pharma Endocrinology Inc	6	$118
Acella Pharmaceuticals, LLC	5	$102
Amgen(2 entities)	6	$91
Sanofi-aventis U.S. LLC	5	$87
Medtronic	5	$85
Johnson & Johnson	6	$85
Astellas Pharma US Inc	4	$78
Esperion Therapeutics, Inc.	4	$76
Kowa Pharmaceuticals America, Inc.	3	$72
Merck	4	$68
BD	3	$62
Recordati_rare_diseases_inc.	1	$62
Tolmar, Inc.	3	$61
Halozyme Inc	3	$59
Acerus Pharmaceuticals Corporation	3	$52
Eisai Inc.	3	$49
Azurity Pharmaceuticals, Inc.	2	$45
Ultragenyx Pharmaceutical Inc.	2	$41
Aytu Biopharma, Inc.	2	$38
GSK	2	$31
Shire North American Group Inc	2	$30
Vistapharm, Inc.	2	$30
Sequel Med Tech, LLC	1	$29
Novartis	2	$27
Ascensia Diabetes Care US Inc.	1	$23
Radius Health, Inc.	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
GRT US Holding, Inc.	1	$18
Pfizer	1	$18
Lifescan, Inc.	1	$16
Idorsia Pharmaceuticals US Inc	1	$14
Zealand Pharma US, Inc.	1	$14
Amphastar Pharmaceuticals, Inc.	1	$13

How this compares

$6,953 in reported general payments places this provider in the 55th percentile of 95 endocrinology, diabetes & metabolism providers in Louisiana.

See all endocrinology, diabetes & metabolism providers in Louisiana →

Medicare billing

Part B allowed, 2024

$85,672

Medicare patients

263

Services billed

822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Metairie

Tuan Huy TranMetairie$2M
Jonathan WiseMetairie$463K
Julie TalaveraMetairie$49K
Joseph MurrayMetairie$7K
Harold MillerHammond$1.1M
Timothy GilbertBaton Rouge$985K
Justin FontenotLafayette$905K
Vivian FonsecaNew Orleans$700K
Frank GreenwayBaton Rouge$669K
Abdul KhanHammond$587K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →